Biography:
As an Oncology and Hematology Clinical Nurse Specialist, I have responsibilities at The Johns Hopkins Hospital and Health System level. I serve as the nurse leader overseeing the content and development of policies related to safe handling, chemotherapy and biotherapy, and vascular access devices (VADs). I chair the Hospital’s inter professional vascular access committee. In this role, I am responsible for ensuring that evidence-based practice is used throughout the Institution to guide all aspects of VAD insertion and maintenance to prevent complications, including central line-associated blood stream infections (CLABSIs).
Nationally, I am an active member of the Oncology Nursing Society (ONS). I am co-editor of the ONS Safe Handling of Hazardous Drugs Guidelines (in press, 2017) and co-editor for the ONS Chemotherapy and Biotherapy Guidelines and Recommendations for Practice (2014), which has sold over 97,000 copies. These publications are internationally used by nurses to guide evidence-based practice. I serve on the American Society of Clinical Oncology (ASCO) and ONS Chemotherapy Safety Standards Workgroup (2016). These guidelines and standards are extensively used by health care providers who prescribe, dispense, and administer chemotherapy in the U.S and internationally. Additionally, I have presented both nationally and internationally, on the topic of safe handling of hazardous drugs.
Title : Safe handling of Hazardous Drugs (HDs): Keeping health care providers safe at work